Jamshidian-Tehrani Mansooreh, Kashkouli Mohsen Bahmani, Ghahvehchian Hossein, Amini Mohammad
Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Skull Base Research Center, Eye Research Center, The Five Senses Health Institute, Rassoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.
J Curr Ophthalmol. 2023 Apr 29;34(4):486-488. doi: 10.4103/joco.joco_98_22. eCollection 2022 Oct-Dec.
To describe superficial temporal artery graft as a new autologous tissue to reconstruct the upper lacrimal drainage system.
We explain the history of a 30-year-old female with upper lacrimal drainage system obstruction, in whom conjunctivodacryocystorhinostomy (CDCR) failed to resolve epiphora. A superficial temporal artery graft was harvested, intubated with Masterka tube, and implanted between the conjunctiva and nasal cavity. Masterka was replaced with a thicker dummy tube 12 weeks postoperatively. The adequacy of the graft was checked with irrigation tests in follow-up visits from 1 to 26 months after the procedure.
Superficial temporal artery autograft successfully eliminated epiphora of the patient in whom (CDCR) with Jones tube failed to make her symptom free.
Superficial temporal artery autograft as an autogenous tissue with adequate characteristics can be considered in selective patients of upper lacrimal obstruction to reconstruct the lacrimal drainage system.
描述颞浅动脉移植作为一种新型自体组织用于重建上泪道引流系统。
我们阐述了一名30岁患有上泪道引流系统阻塞的女性患者的病史,该患者行结膜泪囊鼻腔吻合术(CDCR)后溢泪症状仍未缓解。取一段颞浅动脉进行移植,置入Masterka管,然后将其植入结膜与鼻腔之间。术后12周,将Masterka管更换为较粗的假管。在术后1至26个月的随访中,通过冲洗试验检查移植血管的通畅情况。
颞浅动脉自体移植成功消除了该患者的溢泪症状,此前该患者行带Jones管的结膜泪囊鼻腔吻合术未能使其症状缓解。
对于选择性的上泪道阻塞患者,颞浅动脉自体移植作为一种具有合适特性的自体组织,可考虑用于重建泪道引流系统。